UAEM CALLS ON INDIAN GOVERNMENT TO RECONSIDER LEGISLATION REGARDING THE PATENTING OF PUBLICLY-FUNDED RESEARCH
UAEM CALLS ON INDIAN GOVERNMENT TO RECONSIDER LEGISLATION REGARDING THE PATENTING OF PUBLICLY-FUNDED RESEARCH
Legislation Threatens Access to Medicines and Future Innovative Research
November 6, 2008
Berkeley, CA - Universities Allied for Essential Medicines (UAEM), an international student advocacy group, today called on the Indian government to reconsider legislation that would govern the patenting of the results of publicly funded-research including publicly-funded medical research. The goals of the legislation are unclear and as currently written, the bill would likely harm access to medicines and impede the ability of scientists to conduct innovative research.
Proponents of the Indian bill claim it will help India to commercialize publicly-funded research by encouraging research institutions to seek patents. UAEM today issued a white paper raising questions about the impacts of university patenting in the United States under the Bayh-Dole Act while offering analysis of the Indian bill. The Indian bill is modeled after the Bayh-Dole Act of 1980, which encouraged research institutions to seek patents and commercialize discoveries made through publicly-funded research. While patenting has risen since the passage of Bayh-Dole, it has also expanded into areas of basic research where patents prevent other research from using basic tools to conduct life-saving research. Read more »